Sign In
Buy QDEL
$13.60
+0.310 (+2.33%)
At Close: Jun 03, 2026
What Makes QuidelOrtho (QDEL) a New Buy Stock
01:00pm, Wednesday, 18'th Jun 2025
QuidelOrtho (QDEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term
10:51am, Wednesday, 18'th Jun 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Value Investors Buy QuidelOrtho (QDEL) Stock?
10:41am, Wednesday, 18'th Jun 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics
04:10pm, Tuesday, 03'rd Jun 2025
―Company Intends to Acquire LEX Diagnostics Upon U.S. FDA Clearance― ―Company Plans to Discontinue Savanna® Platform Development― ―Company Reaffirms Full Year 2025 Financial Guidance ― �
Why QuidelOrtho (QDEL) is a Top Momentum Stock for the Long-Term
10:56am, Tuesday, 03'rd Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why QuidelOrtho (QDEL) is a Strong Growth Stock
10:51am, Monday, 02'nd Jun 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
QuidelOrtho to Participate in Upcoming Investor Conferences
04:30pm, Thursday, 22'nd May 2025
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical l
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
10:46am, Wednesday, 21'st May 2025
QDEL continues to witness growth on the back of its strong product portfolio.
Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term
10:50am, Thursday, 15'th May 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade)
09:30am, Monday, 12'th May 2025
Despite a once promising future, QuidelOrtho Corporation's current prospects are unappealing. I rated QuidelOrtho as a "Buy" in July 2023, but the stock has since declined by ~60% as its growth has st
QuidelOrtho Stock Gains Following Q1 Earnings Beat, Margins Expand
01:10pm, Thursday, 08'th May 2025
Despite solid performances by the Labs and Immunohematology units and EMEA and Other regions, QDEL reports soft overall top-line results in first-quarter 2025.
QuidelOrtho Corporation (QDEL) Q1 2025 Earnings Call Transcript
07:56pm, Wednesday, 07'th May 2025
QuidelOrtho Corporation (NASDAQ:QDEL ) Q1 2025 Results Conference Call May 7, 2025 5:00 PM ET Company Participants Juliet Cunningham - Vice President, Investor Relations Brian Blaser - President and C
QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates
07:10pm, Wednesday, 07'th May 2025
QuidelOrtho (QDEL) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.44 per share a year ago.
QuidelOrtho Reports First Quarter 2025 Financial Results
04:05pm, Wednesday, 07'th May 2025
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN
11:15am, Tuesday, 06'th May 2025
The medical device sector saw steady sales growth in the first quarter of 2025, supported by innovation in AI, wearables, and personalized care. However, earnings gains were more modest as global tari
